Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by tboron Jan 25, 2008 11:23am
215 Views
Post# 14261692

RE: World Economic Forum Announces Technology Pio

RE: World Economic Forum Announces Technology PioCollinc did you ever consider they did not win the award for just RVX-208?  Do you think they just sneezed into a petri dish and thought that what grew could increase HDL?
Maybe they won the award for the technology that lead to the discovery of RVX-208 as well as hundreds of other compounds.

"Resverlogix Corp. ("Resverlogix") (TSX:RVX) is pleased to announce today that the World Economic Forum has selected Resverlogix as a winner of the very prestigious Technology Pioneer Award in recognition of its NexVas(TM) Plaque Removal program. Candidates for this award must be involved in the development of life-changing technologies and have potential for long-term impact on business and society....

The NexVas(TM) program is the Company's primary focus which is to develop novel small molecules that enhance ApoA-I."

Nowhere in the NR does it say that RVX won the award for RVX-208.

Part of the value of RVX is 208, but another huge part is the technology behind 208.  RVX has thousands of patents on hundreds of compounds.  This is why the longs are so excited about this company, it is not just a one horse show.  This is also why I believe that a deal will be done.  I hope sooner rather than later but that is not up to me.

You know you have been posting useless posts on this board for what, 8 months?  Maybe you should spend a little time actually researching RVX instead of searching the web for obscure info from sketchy sources. 

And stopping harping on the fact Amorak made a little money,  did you buy at $29, and are now pi$$ed because you got burned.  If you take buying and selling advice from any stock board you are not a bright as you think you are.  I bought a ton of shares at $4, should I have held every single share when I was sitting on a 700% gain?  Give your head a shake.  Stop being so argumentative and open you eyes.
Bullboard Posts